Pathophysiology of lung cancer Flashcards

1
Q

Discuss the epidemiology of lung cancer

A

Epidemiology of Lung Cancer

  • In 2007, lung cancer was the 4th most commonly diagnosed cancer in both males and females.
  • 80% were over 60 years old.
  • Deaths decreased by 32% in men and increased by 72% in females, leading to similar death rates.
  • 5-year survival rates were 11% for males and 15% for females (2000–2007).
  • Approximately 1 in 6 Australian adults smoke.

Epidemiology of Lung Cancer Statistics

Global Incidence

  • 1.3 million deaths/year worldwide.
  • Lung cancer causes more deaths than any other cancer.
  • Leading cause of death in men and second in women.
  • 5-year survival rate remains at 14%.
  • Risk factors: radon, asbestos, air pollution.
  • Tobacco smoke responsible for 87% of lung cancer cases.

President Clinton August 23, 1996: “Cigarette smoking is the most significant public health problem facing our people. More Americans die every year from smoking-related diseases than from AIDS, car accidents, murders, suicides, and fires — combined.”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Discuss the various consequences of smoking

A
  • Cancers
    • Atherosclerosis, cardiovascular disease
    • Respiratory diseases: Asthma, Chronic Bronchitis, Emphysema, Respiratory Bronchiolitis (RB)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

List smoking related cancers

A
  • Mouth, nose, and throat
  • Larynx
  • Trachea
  • Esophagus
  • Lungs
  • Stomach
  • Pancreas
  • Liver
  • Kidneys and ureters
  • Bladder
  • Colon and rectum
  • Cervix
  • Bone marrow and blood (leukemia)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Discuss the relatiosnhip between smoking and lung cancer

A
  • Relationship between smoking and lung cancer depends on:
    1. Amount of daily smoking?
    2. Tendency to inhale?
    3. Duration of smoking?
    4. Age of initiation of smoking.
  • The Cancer Prevention Study found that:
    • 1 pack per day = 22 times the risk of dying from lung cancer.
    • 2 packs per day = 45 times the risk of dying from lung cancer.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Discuss the risks of smoking and lung cancer

A

Smoking and Lung Cancer Risks

  • Risk significantly decreases when smoker stops; takes 15 years to approach non-smoker risk.
  • Passive smoking (second-hand smoke): Risk is 1.25 times higher for individuals in a non-smoking environment.

Second-Hand Smoke and Children

  • Second-hand smoke causes various health issues in children, including sudden infant death syndrome, ear infections, colds, pneumonia, bronchitis, and more severe asthma.
  • increases a non-smoker’s chances of developing lung cancer by 20
  • to 3 for other cancers
  • causes 3000 lung cancer deaths per year

Smoking during Pregnancy

  • Smoking during pregnancy leads to complications, premature birth, low-birth-weight infants, stillbirth, abruption, ectopic pregnancy, preterm delivery, and more.
  • before pregnancy: causes infertility, and worse response to IVF
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Discuss the common presentations of lung cancer

A

Common Presentations

  • Asymptomatic (by chance, usually on CXR done for other reasons) - 15%
  • Cough - 45-74%
  • Weight loss - 46-68%
  • Dyspnoea - 37-58%
  • Chest pain - 27-49%
  • Haemoptysis - 30%
  • Bone pain - 20%
  • Hoarseness - 8-18%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

List some paraneoplastic syndromes associated with lung cancer

A

Paraneoplastic syndromes are a group of clinical disorders that are associated with malignant diseases and are not directly related to the physical effects of the primary or metastatic tumours
Neuromuscular
- Polymyositis
- Myasthenic Syndrome
- Sensorimotor Neuropathy
- Encephalopathy
- Myelopathy
- Cerebellar Degeneration

Endocrine
- Superficial Thrombophlebitis
- Thrombosis
- Marantic Endocarditis
- Cushing’s Syndrome
- SIADH (Syndrome of Inappropriate Antidiuretic Hormone)
- Hypercalcaemia
- Carcinoid Syndrome
- Gynaecomastia
- Hyperglycaemia
- Galactorrhoea
- GH (Growth Hormone) Excess
- TSH (Thyroid Stimulating Hormone) Excess
- Calcitonin Secretion

Musculoskeletal/Cutaneous
- Clubbing
- Dermatomyositis
- Acanthosis Nigricans
- Pruritis
- Urticaria
- Erythema Multiforme
- Hyperpigmentation

Hematological
- Haemolytic Anaemia
- Red Cell Aplasia
- Polycythaemia
- Thrombocytopenic Purpura
- Thrombocytosis
- Dysproteinaemia
- Eosinophilia
- Leuco-erythroblastic Reaction
- Nephrotic Syndrome
- Hyperuricaemia
- Amyloidosis
- Secretion of Alkaline Phosphatase
- Secretion of IgA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Disucss the risk factors for lung cancer

A
  • Smoking:
    • Primary risk factor accounting for 90% of lung cancers.
    • Squamous and small cell lung carcinoma have the strongest correlation with tobacco exposure
    • Adenocarcinoma has the weakest association with smoking.

Other Risk Factors

  • Asbestos exposure
  • Radon exposure
  • Halogen ether exposure
  • Chronic interstitial pneumonitis
  • Smoking + Beta-carotene (Vitamin A) supplements (with alcohol)
  • Inorganic arsenic exposure
  • Radioisotope exposure, ionizing radiation
  • Atmospheric pollution
  • Chromium, nickel exposure
  • Vinyl chloride exposure
  • Possible HIV association
  • Genetic polymorphisms (CYP1A1 system)

Lung Cancer in Non-Smokers

  • 10-25% of lung cancer cases.
  • Women are more affected (possible hormonal element).
  • Passive smoking and workplace carcinogens are contributing factors.
  • Adenocarcinomas are more common.
  • Genetic factors, such as EGFR mutations and EML4-ALK fusions, play a role in young Asian non-smokers.
  • Decreased incidence of p53 mutations and KRAS mutations.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Distinguish between the normal lung and the smoker’s lung*

A

Recall: normal bronchial mucosa have 4 cell types: ciliated, mucous, neuro-endocrine and basal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe the pathophysiology of smoking

A

Squamous Metaplasia –> Dysplasia –> Carcinoma in Situ

Atypical Adenomatous Hyperplasia (AAH) and Bronchioloalveolar Carcinoma (BAC)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Discuss the classification of lung carcinoma

A

Classification of Lung Carcinoma

  • Small Cell Lung Carcinoma (SCLC)
    VERSUS
  • Non-Small Cell Carcinoma (NSCLC)

Lung Cancers

  • Small Cell Lung Cancer (15%)
  • Non-Small Cell Lung Cancer (85%)
    • Adenocarcinoma: 35-40%
    • Squamous Cell Carcinoma (SCC): 25-30%
    • Large Cell (Neuroendocrine) Carcinoma: 10-15%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

List reasons for the importance of tumour classification

A
  • Prognosis
  • Treatment
  • Pathogenesis/Biology
  • Epidemiology
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe adenocarcinoma

A
  • Peripherally located and slower growing
  • Disseminate widely early in disease progression
  • Most common primary tumor in:
    • Women
    • Lifetime non-smokers
    • Patients <45 years old
  • Histology: Acinar, papillary & solid types, mucin production
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe squamous carcinoma

A
  • Commonest tumor type
  • More common in males
  • Centrally hilar located in major bronchi
  • Spread to local hilar lymph nodes
  • Extra-thoracic dissemination occurs later
  • Histology: Keratin pearl formation, intercellular bridges
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe small cell carcinoma

A
  • Centrally located
  • Rapid growth and early dissemination to hilar/mediastinal LNs
  • Primary tumor may be difficult to find
  • Derived from neuroendocrine cells of lung
  • Surgery not the mainstay of treatment
  • Microscopically: cells have very little cytoplasm, cells show molding, hyperchromatic cells with salt-pepper chromatin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe large cell carcinoma

A
  • Lack cytological differentiation; large cells with large nuclei
  • Giant cell & spindle cell variants
  • Central or peripheral location
  • Poor prognosis; spread to distant sites early
  • Microscopy: Undifferentiated, Spindle cells, Giant cells
17
Q

Discuss the overall survival of lung cancer

A

Overall 5-Year Survival

  • 12.5% in 1975.
  • US data collected from 1995-2001 indicate:
    • 5-year relative survival rate for lung cancer was 15.7%
    • 49% survival for local disease
    • 16% survival for regional disease
    • 2% survival for distant stage disease
18
Q

Describe the staging types

A
  • Tumor type
  • Tumor grade
  • Vascular space invasion
  • Status of pleura
  • Status of bronchial resection margins
  • Status of resected nodes
19
Q

Discuss the importance of staging

A
  • I, early, surgery
  • II, mid, +/- radiation
  • III, mid, +/- chemo
  • IV, advanced, chemotherapy
20
Q

Discuss newer treatment directions

A

New Directions

  • Targeting molecular changes in tumor cell biology, promising
  • Gene inhibition for epithelial surface relay, monoclonal antibodies to block genes
  • Growth factor inhibitors
  • EGFR mutation
    • Activating mutations in the epidermal growth factor receptor (EGFR) gene occur in 10–20% of Caucasian and at least 50% of Asian non-small cell lung cancer (NSCLC) patients
  • FISH - gene rearrangement (ALK, ROS1)
  • PD-L1 expression testing for immunotherapy: if >50% = eligible
    • LUAD and SCC

Molecular era
- LUAD primary for EGFR
- if positive, treated with inhiioss eg gefitinib
- Primary SCC not eyet sent for muattional analysis (onlt PD-L1 testing)